Compare MNPR & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNPR | GROY |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 587.4M | 702.0M |
| IPO Year | 2019 | 2020 |
| Metric | MNPR | GROY |
|---|---|---|
| Price | $70.28 | $2.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $130.17 | $5.03 |
| AVG Volume (30 Days) | 127.0K | ★ 1.6M |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $121.78 |
| Revenue Next Year | N/A | $32.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $50.07 | $2.45 |
| 52 Week High | $124.82 | $5.45 |
| Indicator | MNPR | GROY |
|---|---|---|
| Relative Strength Index (RSI) | 42.77 | 36.09 |
| Support Level | $66.88 | N/A |
| Resistance Level | $75.33 | $2.72 |
| Average True Range (ATR) | 4.74 | 0.14 |
| MACD | 0.73 | -0.03 |
| Stochastic Oscillator | 51.81 | 0.57 |
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.
Gold Royalty Corp is principally engaged in acquiring gold-focused royalties, streaming, and similar interests. It is a gold-focused royalty company offering creative financing solutions to the metals and mining industry. The Company operates in Bosnia and Herzegovina, Canada, which generates maximum revenue, the USA, Brazil, and Mexico.